UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

Clinical pharmacokinetics, 2013-04, Vol.52 (4), p.225-241

2013

Volltextzugriff (PDF)

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Schizophrenia bulletin, 2018-02, Vol.44 (2), p.317-327

2018

Volltextzugriff (PDF)

Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior

Human molecular genetics, 2016-12, Vol.25 (24), p.5472

2016

Volltextzugriff (PDF)

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

Clinical pharmacokinetics, 2015-12, Vol.54 (12), p.1259-1272

2015

Volltextzugriff (PDF)

Blood Pressure in Relation to Coffee and Caffeine Consumption

Current hypertension reports, 2014-09, Vol.16 (9), p.468-468, Article 468

2014

Volltextzugriff (PDF)

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication

PloS one, 2020-12, Vol.15 (12), p.e0242569

2020

Volltextzugriff (PDF)

Associations between antipsychotics-induced weight gain and brain networks of impulsivity

Translational psychiatry, 2024-03, Vol.14 (1), p.162-162, Article 162

2024

Volltextzugriff (PDF)

Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort

Translational psychiatry, 2024-08, Vol.14 (1), p.330-13, Article 330

2024

Volltextzugriff (PDF)

Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC–MS

Journal of pharmaceutical and biomedical analysis, 2009-12, Vol.50 (5), p.1000-1008

2009

Volltextzugriff (PDF)

Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients

Frontiers in psychiatry, 2024-02, Vol.15, p.1256416-1256416

2024

Volltextzugriff (PDF)

Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring

Journal of pharmaceutical and biomedical analysis, 2014, Vol.88, p.36-44

2014

Volltextzugriff (PDF)

Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers

Pharmacogenetics and genomics, 2013-05, Vol.23 (5), p.286-292

2013

Volltextzugriff (PDF)

CYP2C19 expression modulates affective functioning and hippocampal subiculum volume—a large single-center community-dwelling cohort study

Translational psychiatry, 2022-08, Vol.12 (1), p.316-316, Article 316

2022

Volltextzugriff (PDF)

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project

Frontiers in psychiatry, 2023-05, Vol.14, p.1167870

2023

Volltextzugriff (PDF)

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance

British journal of clinical pharmacology, 2014-07, Vol.78 (1), p.135-144

2014

Volltextzugriff (PDF)

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort

Translational psychiatry, 2021-06, Vol.11 (1), p.360-360, Article 360

2021

Volltextzugriff (PDF)

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution

Clinical and translational science, 2021-11, Vol.14 (6), p.2544-2555

2021

Volltextzugriff (PDF)

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort

Frontiers in psychiatry, 2021-12, Vol.12, p.756403-756403

2021

Volltextzugriff (PDF)

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response

Therapeutic drug monitoring, 2008-08, Vol.30 (4), p.474-482

2008

Volltextzugriff (PDF)

Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression

Translational psychiatry, 2017-12, Vol.7 (12), p.1269-12, Article 1269

2017

Volltextzugriff (PDF)

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression

PloS one, 2015-10, Vol.10 (10), p.e0139155-e0139155

2015

Volltextzugriff (PDF)

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort

Translational psychiatry, 2021-10, Vol.11 (1), p.512-512, Article 512

2021

Volltextzugriff (PDF)

The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants

Obesity surgery, 2023-05, Vol.33 (5), p.1422-1430

2023

Volltextzugriff (PDF)

1 – 25 von 248

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(236)
Mit Volltextzugriff
(176)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(195)
Life Sciences & Biomedicine
(192)
Humans
(164)
Female
(118)
Male
(110)
Pharmacology & Pharmacy
(109)
Adult
(96)
Middle Aged
(84)
Psychiatry
(82)
Biological And Medical Sciences
(73)
Medical Sciences
(71)
Pharmacology. Drug Treatments
(57)
Aged
(42)
Genotype
(33)
Adolescent
(26)
Psychopharmacology
(26)
Neurosciences
(25)
Stereoisomerism
(25)
Toxicology
(25)
Psychology. Psychoanalysis. Psychiatry
(24)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease

N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis

Genome-wide association study of caffeine metabolites provides new insights to caffeine metabolism and dietary caffeine-consumption behavior

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

Blood Pressure in Relation to Coffee and Caffeine Consumption

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication

Associations between antipsychotics-induced weight gain and brain networks of impulsivity

Long-term changes in adiposity markers during and after antidepressant therapy in a community cohort

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort

Therapeutic drug monitoring of seven psychotropic drugs and four metabolites in human plasma by HPLC–MS

Metabolic disturbances are risk factors for readmission to psychiatric hospitals in non-smokers but not in smokers: results from a Swiss psychiatric cohort and in first-episode psychosis patients

Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring

Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers

CYP2C19 expression modulates affective functioning and hippocampal subiculum volume—a large single-center community-dwelling cohort study

Publisher Correction: Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort

Infant exposure to Fluvoxamine through placenta and human milk: a case series - A contribution from the ConcePTION project

Population pharmacokinetic approach to evaluate the effect of CYP2D6, CYP3A, ABCB1, POR and NR1I2 genotypes on donepezil clearance

Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort

Metabolomic alteration induced by psychotropic drugs: Short‐term metabolite profile as a predictor of weight gain evolution

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort

CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response

Gender-specific alteration of energy balance and circadian locomotor activity in the Crtc1 knockout mouse model of depression

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression

Correction: Socio-economic position as a moderator of cardiometabolic outcomes in patients receiving psychotropic treatment associated with weight gain: results from a prospective 12-month inception cohort study and a large population-based cohort

The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants

Suchergebnisse filtern